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Background/aim: Alprostadil and iloprost are successful agents used for both pulmonary hypertension and extremity ischemia
treatment. Different systemic effects of these agents may change the preferences of clinical usage. Superiority of preventing ischemia/
reperfusion (IR) injury is a criterion for clinical preference of these agents. The present study was designed to compare the protective
effects of alprostadil and iloprost in a rat model of IR injury.
Materials and methods: Twenty-three male Sprague Dawley rats were used (aged 8-12 weeks, mean weight 230 ± 30 g). They were
randomized into 4 groups: Group 1 (iloprost + IR), Group 2 (alprostadil + IR), Group 3 (saline + IR), and Group 4 (control). Under
general anesthesia, in all groups except Group 4, the abdominal region was explored and the abdominal aorta was temporarily
clamped for 60 min. After the clamp was removed, 120 min of reperfusion was applied. In Group 4, the rats were placed under general
anesthesia and abdominal exploration was performed without the IR procedure. For all rats, body temperature was kept at 36 °C with
a heater pad through the whole procedure. The rats were euthanized under general anesthesia to remove the kidneys and lungs for
study. Histopathological and biochemical analyses were conducted with kidney and lung tissues. Histopathological scoring was done
by analyzing cellular damage at tissue level. Malondialdehyde (MDA), superoxide dismutase, and glutathione levels were studied for
biochemical analysis.
Results: Histopathologic analysis showed that, as compared with alprostadil, iloprost provided a significantly higher level of renal
protection against IR injury (P < 0.01). Renal tissue levels of MDA were significantly lower in the alprostadil group as compared to
Group 3 (P < 0.05).
Conclusion: Alprostadil and iloprost seem to provide protection against IR injury, with iloprost being more protective in renal tissue.
Alprostadil is more effective than iloprost in protecting lung tissue against IR injury.
Key words: Reperfusion injury, alprostadil, iloprost, lung, kidney

1. Introduction
Ischemia/reperfusion (IR) injury refers to a series of
pathophysiologic processes that occur along with the
return of blood to tissues after an ischemic period. The
reperfusion of ischemic tissue can lead to catastrophic
damage to cellular structures, membrane lipids, and
proteins (1). Multiple interactions between free oxygen
radicals, lymphocytes, cytokines, the complement system,
and endothelial cells play a major role in the reperfusion
process (2,3). Alprostadil (PGE1) is a vasodilator agent that
has an inhibitory effect on platelet aggregation. It is also
used as a regulatory element in IR injury for inhibition of
* Correspondence: dnzcvr@hotmail.com

the immune system and reduction of free oxygen radicals
(4). Iloprost has shown favorable results in critical limb
ischemia (5). It also decreases neutrophil adhesion and
platelet aggregation, helping to prevent organ damage in
IR injury (6).
Damage to the cell membranes as a result of the IR
process leads to the release of lipid peroxidation products.
Malondialdehyde (MDA) is one of the end products of
IR injury and has been commonly used as a marker of
tissue damage. On the other hand, superoxide dismutase
(SOD) and glutathione (GSH) have antioxidant effects that
limit the resulting damage; thus, their levels also provide
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information about the extent of damage (7,8). The present
study was designed to compare the use of alprostadil and
iloprost in a rat model of IR injury.
2. Materials and methods
2.1. Study design
This randomized, controlled, single-blind, interventional
animal study was conducted in the Experimental Research
Center of the Yeditepe University Faculty of Medicine
(İstanbul, Turkey) after obtaining approval from the local
ethics committee at the same center. The experiments
were performed in accordance with the Guide for the
Care and Use of Laboratory Animals (9).
Twenty-three male Sprague Dawley rats were used.
These rats were aged 8-12 weeks and weighed 230 ± 30 g.
The rats were kept free in cages on a 12-h light-dark cycle
under constant environmental conditions (temperature
22 ± 2 °C, humidity 50 ± 5%) and given ad libitum feed
and water. The rats were randomized into 4 groups:
Group 1 (iloprost + IR) and Group 2 (alprostadil + IR)
each included 7 rats receiving iloprost or alprostadil,
respectively. The 5 rats in Group 3 (saline + IR) received
0.9% isotonic saline solution, and there were 4 rats in
Group 4 (control).
2.2. Surgical procedure
All rats underwent inhalational anesthesia with isoflurane
(Isoflurane USP, Adeka, Turkey). The induction and
maintenance of anesthesia was performed with a mixture
of 2% isoflurane and 100% O2 delivered at a rate of 2 L/
min through a breathing mask. The body temperature of
all rats was kept at 36 °C with a heater pad through whole
procedure.
Temporary abdominal aorta clamping and removal of
the clamp to reperfuse the lower extremities for 120 min
has been defined as the IR rat model (10,11).

After the rats were anesthetized in the supine position,
the skin over the abdominal area was shaved and cleaned
with povidone iodine, and an abdominal incision of about
5 cm was made in the midline. The intestines were moved
aside, and the abdominal aorta and inferior vena cava were
exposed. Then a 22-G needle was inserted into the inferior
vena cava for intravenous infusion. The abdominal aorta
was clamped temporarily at the infrarenal aorta, sparing
the visceral arteries just above the iliac bifurcation. The
clamping lasted for 60 min, during which the ischemia
of the lower limbs was monitored by color change in the
limbs and pulselessness. The rats were monitored for pulse
rate, saturation, and heart rate via a Covidien Nellcor. Both
the upper and lower extremities were monitored during
the ischemia and reperfusion period. The intestines were
covered with isotonic solution-soaked wet gauzes to
protect the abdominal cavity from intestinal ischemia and
damage (Figure 1). Thereafter, the clamp was removed
to allow reperfusion for 2 h. In the 3 study groups, the
infusions lasted for 180 min, from the time of clamping to
the end of the reperfusion period.
The infusion doses were as follows: Group 1, iloprost
at 2 µg/kg hourly (iloprost + IR); Group 2, alprostadil at
0.1 mg/kg per minute (alprostadil + IR); Group 3, 0.9%
isotonic saline solution at 2 mL/kg hourly (saline + IR). All
infusions were delivered using an infusion pump (Aitecs
2016, Aitecs, Lithuania).
2.3. The control group
All the rats in Group 4 underwent general anesthesia via
inhalation for 3 h (180 min) and an abdominal incision,
without an IR process or inferior vena cava cannulation.
2.4. Sample collection and sacrifice procedure
After 3 h, each rat was euthanized under general anesthesia
in compliance with the ethical standards for the care and
use of laboratory animals. First the kidneys were removed,

Figure 1. a- Monitoring, b- breathing mask, c- heater pad, *- wet gauze.
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followed by the removal of the lungs. The right kidney and
the right lung were immediately frozen and stored at -80
°C for biochemical and marker analyses. The left kidney
and left lung were fixed in 10% formaldehyde solution for
histopathologic examination. The rats were euthanized
through organ harvesting under general anesthesia with
isoflurane.
2.5. Histopathologic evaluation
IR injury was performed according to previously published
data (12).
After fixation in 10% formaldehyde solution and
routine histological preparation (13), the kidney and
lung tissues were embedded in paraffin. These paraffinembedded tissue blocks were cut to a thickness of 5 µm
and the slices were stained with hematoxylin and eosin.
Slides were examined and photographed under a Leica
photomicroscope (Germany). Histopathologic scoring was
performed as follows according to previously published
data (13), with total maximum histopathologic scores of

9 for the lung and the kidney separately: each criterion
was rated with a score from 0 to 3, indicating no, slight,
moderate, or severe damage.
The criteria for the microscopical histopathologic
scoring for the lung included (i) interstitial edema and
vascular congestion, (ii) alveolar structural disturbance,
and (iii) inflammatory cell infiltration. The corresponding
criteria for the kidney included (i) interstitial edema and
vascular congestion, (ii) renal tubular degeneration, and
(iii) renal corpuscle degeneration (Figures 2 and 3).
2.6. Biochemical analysis
The biomarkers analyzed in the tissue samples included
MDA, SOD, and GSH. Biomarker quantification was
performed according to the methods previously described
by Akkaya et al. (14). Tissue MDA levels were determined
spectrophotometrically via a modification to the method
described by Placer et al. (15). During the peroxidation
of fatty acids containing 3 or more double bonds, MDA
is formed, which is measurable via the thiobarbituric

Figure 2. Histopathologic kidney samples. A) Normal glomeruli and tubular structures are seen in the control
group. B) Severe degeneration of glomeruli (*) and tubules (→) with vascular congestion (h) and inflammatory cell
infiltration (▲) in the IR group. C) Severe degeneration of glomeruli (*) and tubules (→) with vascular congestion
(h), inflammatory cell infiltration (▲), and edema (e) in the alprostadil + IR group. D) Moderate degeneration of
glomeruli (*) and tubules (→) with vascular congestion (h) and inflammatory cell infiltration (▲) in the iloprost +
IR group.
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Figure 3. Histopathologic lung samples. A) Normal structures are seen in the control group. B) Severe degeneration
of the alveolar structures (*), inflammatory cell infiltration (▲), edema (e), and vascular congestion (h) in the
IR group. C) Degeneration of alveolar structures (*), inflammatory cell infiltration (▲), edema (e), and vascular
congestion (h) in the alprostadil + IR group. D) Degeneration of alveolar structures (*), inflammatory cell
infiltration (▲), and edema (e) in the iloprost + IR group.

acid (TBA) technique. As an end product of fatty
acid peroxidation, MDA reacts with TBA, forming
a pink complex. This resulting pink color was read
spectrophotometrically at 532 nm.
SOD activity was determined according to a
modification of Sun et al.’s method (16). It was based
on the inhibition of nitroblue tetrazolium reduction
by superoxide, which is formed by the xanthinexanthine oxidase system. The determination of GSH
was performed according to the method described by
Ellman et al. (17). It was measured via an enzymatic
cycling procedure in the presence of 5,5’-dithiobis(2nitrobenzoic acid) (DTNB), nicotinamide adenine
dinucleotide phosphate (NADPH), and glutathione
reductase.
2.7. Statistical analysis
The data were statistically evaluated using one-way
analysis of variance (ANOVA), followed by a Tukey post
hoc test (SPSS 18.0, SPSS Inc., USA). The results are
presented as means ± standard deviations. P < 0.05 was
considered statistically significant.
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3. Results
3.1. Results of histopathologic analyses
For the kidney, in Group 4 (control), no histopathologic
damage was observed. The highest damage score was
found in Group 3 (saline + IR). The damage scores for
Group 1 (iloprost + IR) and Group 2 (alprostadil + IR) were
substantially higher as compared to Group 4 (P < 0.001).
Comparing Groups 2 and 3, the damage score for Group
2 was significantly lower than that for Group 3 (P < 0.05).
In addition, comparing Group 1 and Group 3, the damage
score for Group 1 was found to be significantly lower than
that for Group 3 (P < 0.001). Comparing Group 1 and
Group 2, the damage score for Group 1 was significantly
lower than that for Group 2 (P < 0.001). The comparative
histopathologic results of the renal tissue samples of the 4
groups are shown in Table 1 and Figure 4.
For the lung, the damage score for Group 4 (control)
was the lowest. The damage scores for Groups 1 (iloprost)
and 3 (alprostadil) were close to one another, and the
difference between them was not statistically significant
(P > 0.05). The damage score for Group 2 (alprostadil)

ÇEVİRME et al. / Turk J Med Sci
Table 1. Histopathological results for kidney tissue.
Group 1

Group 2

Group 3

Group 4

1

3

7

9

0

2

2

7

8

0

3

3

7

9

0

4

3

7

9

0

5

1

7

9

6

2

7

7

2

7

Groups

Mean

Std. deviation

Group 1

2.28

0.75

Group 2

7.00

0.0

Group 3

8.80

0.45

Group 4

0.0

0.0

Group 1: Iloprost + IR, Group 2: Alprostadil + IR, Group 3: Saline + IR, Group 4: Control.

10
9
8
7
6
5
4
3
2
1
0

stdev

Group4

mean

Group2

Group1

Group3

Group 1; P < 0,0 01 compared to Group 4
Group 2; P < 0,001 compared to Group 4
Group 3; P < 0,001 compared to Group 4
Group 2; P < 0,05 compared to Group 3
Group 1; P < 0,01 compared to Group 3
Group 1; P < 0,01 compared to Group 2

Figure 4. Comparison of histopathological kidney scores
between groups.

was significantly lower than that for Group 3 (saline + IR)
(P < 0.05). In addition, comparing Group 2 (alprostadil)
and Group 1 (iloprost), the damage score for Group 2
(alprostadil) was found to be significantly lower than that
of Group 1 (P < 0.01) (Table 2 and Figure 5).
3.2. Results of biochemical analyses
Regarding GSH, in Group 4 (control), the GSH levels in
the kidney tissue were the highest, whereas in Group 3
(saline + IR), GSH levels were the lowest. The difference
between Group 4 and Group 3 was statistically significant

(P < 0.05). The GSH level for Group 1 (iloprost) was higher
than that for Group 3 (P < 0.05). Comparing Group 2
(alprostadil) and the other groups, GSH levels were not
statistically significantly different (P > 0.05). For the lung
tissue, there were no statistically significant differences
between the groups (P > 0.05).
Regarding SOD, both lung and kidney tissues showed
no statistically significant differences between the groups.
Regarding MDA, in the kidney tissue, the MDA level
of Group 3 (saline + IR) was higher than that of Group 4
(control), but this finding was not statistically significant.
The MDA levels of Group 1 (iloprost) and Group 2
(alprostadil) were found to be lower than that of Group
3, but a statistically significant difference was found only
between Group 2 and Group 3 (P < 0.05). In the lung
tissue, no statistically significant differences were found
between groups regarding MDA levels (Tables 3 and 4).
4. Discussion
IR injury is a pathological process affecting many organs
in the body, particularly the kidneys, lungs, and heart (18).
In clinical practice, the treatment of this damaging process
remains palliative. Iloprost is beneficial in ischemic
injury, as well as in other pathological processes, such as
infections. It is also an effective agent against pulmonary
hypertension (19,20). Alprostadil has similar effects,
and its use has been examined in the literature (21,22).
Protection against lower limb ischemia, considered in
the context of a multiorgan preservation strategy and the
broad-spectrum preventive effects of both agents, may
represent a challenge in terms of the choice of treatment.

665

ÇEVİRME et al. / Turk J Med Sci
Table 2. Histopathological results for lung tissue.
Group 1

Group 2

Group 3

Group 4

1

9

7

9

3

2

9

8

8

1

3

9

8

9

2

4

9

7

9

3

5

9

7

9

6

9

8

7

9

8

Groups

Mean

Std. deviation

Group 1

9

0.0

Group 2

7.57

0.55

Group 3

8.80

0.45

Group 4

2.25

0.96

Group 1: Iloprost + IR, Group 2: Alprostadil + IR, Group 3: Saline + IR, Group 4: Control.

10

stdev

mean

8
6
4
2
0

Group4

Group2

Group1

Group3

Group 1; P > 0,05 compared to Group 3
Group 1; P < 0,01 compared to Group 2
Group 2; P < 0,05 compared to Group 3

Figure 5. Comparison of histopathological lung scores between
groups.

PGE1 has a vasodilative effect on the pulmonary
arteries. For this reason, PGE1 is used for pulmonary
hypertension treatment. In addition to vasodilation,
PGE1 has a bronchodilative effect, and it is superior to
PGI2 in terms of its vasodepressive effect in lung tissues,
as reported in animal studies (23,24). A histopathologic
study in lung tissue showed that the tissue damage score of
Group 2 (alprostadil + IR ) was lower than those of Group
1 (iloprost + IR) and Group 3 (saline + IR) (P < 0.005).
However, no protective effect of iloprost against IR was
found in lung tissue.
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Alprostadil interacts with specific G protein-coupled
receptors to increase plasma levels of adenosine, which
in turn decreases leukocyte activity, provides endothelial
protection, and inhibits platelet aggregation. These result in
improvements in blood flow and increased oxygen delivery
to tissues (25). Having similar effects, iloprost is an analog
of endogenous PGI2. It provides endothelial protection
via decreasing neutrophil adherence to the vascular
endothelium. Neutrophil stabilization limits tissue damage
by reducing the release of free radicals. Histopathological
studies of tissue samples have shown that both iloprost and
alprostadil protect the kidney from IR injury. The damage
scores for Group 1 (iloprost) and Group 2 (alprostadil)
were lower than that for Group 3 (saline + IR ). Although
alprostadil was found to be protective in kidney tissue, when
comparing Group 1 (iloprost) and Group 2 (alprostadil),
iloprost was found to protect kidney tissue better than
alprostadil did (P < 0.001).
It is difficult to explain why iloprost has more beneficial
effects on renal injury than alprostadil according to the
literature. Konstantinos et al. found iloprost to be successful
among patients with contrast nephropathy. It was shown in
animal studies that PGI2 may reverse renal toxic injury and
attenuate the contrast substance’s effect on the kidneys via
interactions at the cellular level (26). Similarly, it has been
shown that PGI2 has therapeutic effects on anoxic renal
injury in rabbits whose renal arteries were clamped (27).
Vascular modulation in response to ischemic renal injury
is implemented mainly by PGI2 (28). This may be why
iloprost has an effect on renal tissue.
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Table 3. Biochemical results for kidney tissue.
Kidney

*SOD

GSH

MDA

Group 1

0.673 ± 0.13

19.947 ± 2.15

1.609 ± 0.60

Group 2

0.600 ± 0.17

15.735 ± 5.27

1.231 ± 0.33

Group 3

0.576 ± 0.15

10.138 ± 4.63

1.986 ± 0.37

Group 4
Group 4 – Group 3
Group 1 – Group 3
Group 2 – Group 3

0.627 ± 0.19

20.524 ± 3.38

1.736 ± 0.29

P < 0.05
P < 0.05

Group 1: Iloprost + IR, Group 2: Alprostadil + IR, Group 3: Saline + IR, Group 4: Control.
*SOD level between groups is not statistically significant (P > 0.05).

Table 4. Biochemical results for lung tissue.
*Lung

*SOD

*GSH

*MDA

Group 1

0.896 ± 0.51

20.03 ± 3.7

1.344 ± 0.49

Group 2

0.896 ± 0.12

20.73 ± 4.3

1.367 ± 0.53

Group 3

0.800 ± 0.07

21.21 ± 2.8

1.671 ± 0.94

Group 4

1.182 ± 0.24

21.50 ± 7.2

1.544 ± 0.41

Group 1: Iloprost + IR, Group 2: Alprostadil + IR, Group 3: Saline + IR, Group
4: Control.
*Difference between groups is not statistically significant (P > 0.05).

Ischemic injury results in oxygen free radical
production, leading to cellular damage and decreased
GSH levels (29). MDA is an end product of lipid
peroxidation whose levels correlate with the severity of
the resulting damage (30). No significant difference was
found when comparing the GSH levels of kidneys after
administration of iloprost and alprostadil. However, the
GSH level of Group 1 (iloprost + IR) was significantly
higher than that of Group 3 (saline + IR). Likewise,
comparing the kidney MDA levels of the groups, the
MDA level of Group 2 (alprostadil) was lower than that of
Group 3 (saline + IR) (P < 0.05). However, the lung levels
of GSH and MDA remained similar for both iloprost and
alprostadil (P > 0.05).
GSH, MDA, and SOD are commonly used
biomarkers in IR injury studies, but they may not be
appropriate for our experimental setting. The use of
biomarkers that are more specific to kidney and lung
tissues might have resulted in more conclusive findings.

Inhalation anesthesia with isoflurane is used safely for
general anesthesia procedures in rats. Both iloprost and
alprostadil exert a therapeutic effect through vasodilation
at the tissue level. Vascular effects on smooth muscle and
vasodilation improve blood flow and microcirculation,
protecting tissues from ischemic effects. It has previously
been described that isoflurane has therapeutic effects on
IR injury via vasodilation (31). In our study, all groups
inhaled 2% isoflurane at 2 L/min mixed with 100%
oxygen.
In conclusion, alprostadil and iloprost are commonly
used for the treatment of pulmonary hypertension.
These 2 drugs, which can successfully treat pulmonary
hypertension treatment, are also successful in protecting
renal tissue against IR damage. Iloprost has more
beneficial effects in terms of protecting renal tissue against
IR damage than alprostadil. In contrast, alprostadil has
beneficial effects in terms of protecting lung tissue against
IR damage, but no such effect is present for iloprost.
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